Listed

LifeMD, Inc.

LFMDNasdaqCIK 948320HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$47.3mRevenue, Q2 FY2026, three months to 2026-06-30$47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 5, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$47.3mRevenue, Q2 FY2026, three months to 2026-06-30$47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure−3.5% on a year earlier
  • Gross margin88.8%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $42.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Revenue: $47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure+2.8 pts on a year earlier
  • Operating margin−15.1%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Revenue: $47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure−10.3 pts on a year earlier
  • Net margin−15.0%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Revenue: $47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure−11.7 pts on a year earlier
  • Diluted EPS−$0.16Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure−220.0% on a year earlier
  • Free cash flow−$7.0mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001493152-26-036200. Derived: 6-month figure less the 3-month figure.Capital expenditure: $67.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001493152-26-036200. Derived: 6-month figure less the 3-month figure.Report this figureSign changed from a year earlier

Last eight quarters

Full statements
Revenue$47.3mGross margin 88.8%
Diluted EPS−$0.16, Q2 FY2026
Free cash flow−$7.0m, Q2 FY2026
LifeMD, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m53.3Revenue, Q3 FY2024, three months to 2024-09-30$53.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Report this figure5.5Revenue, Q4 FY2024, three months to 2024-12-31$5.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Report this figure50.9Revenue, Q1 FY2025, three months to 2025-03-31$50.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Report this figure49.0Revenue, Q2 FY2025, three months to 2025-06-30$49.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure60.2Revenue, Q3 FY2025, three months to 2025-09-30$60.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Report this figure7.1Revenue, Q4 FY2025, three months to 2025-12-31$7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Report this figure50.2Revenue, Q1 FY2026, three months to 2026-03-31$50.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Report this figure47.3Revenue, Q2 FY2026, three months to 2026-06-30$47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure
Gross margin%90.6%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $48.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Revenue: $53.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Report this figure(24.0%)Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: −$1.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Revenue: $5.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Report this figure84.0%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $42.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Revenue: $50.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Report this figure86.0%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $42.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Revenue: $49.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure87.7%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $52.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Revenue: $60.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Report this figure40.2%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $2.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Revenue: $7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Report this figure88.2%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $44.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Revenue: $50.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Report this figure88.8%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $42.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Revenue: $47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure
Operating margin%(7.5%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Revenue: $53.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Report this figure(108.8%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Revenue: $5.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Report this figure(2.3%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Revenue: $50.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Report this figure(4.8%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Revenue: $49.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure(3.3%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Revenue: $60.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Report this figure(87.9%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Revenue: $7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Report this figure(17.8%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$8.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Revenue: $50.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Report this figure(15.1%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Revenue: $47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure
Net margin%(8.7%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Revenue: $53.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Report this figure(90.0%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Revenue: $5.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Report this figure(0.4%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$183.8k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Revenue: $50.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Report this figure(3.3%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Revenue: $49.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure(6.3%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$3.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Revenue: $60.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Report this figure282.0%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $20.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Revenue: $7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Report this figure(17.7%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Revenue: $50.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Report this figure(15.0%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Revenue: $47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure
Diluted EPS$ per share(0.13)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-17, accession 0001493152-25-023906.Report this figurenot reported (Diluted EPS not reported)(0.02)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Report this figure(0.05)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figurenot reported (Diluted EPS not reported)not reported (Diluted EPS not reported)(0.20)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Report this figure(0.16)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001493152-26-036200.Report this figure
Free cash flow$m6.3Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-17, accession 0001493152-25-023906. Derived: 9-month figure less the 6-month figure.Capital expenditure: $447.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-17, accession 0001493152-25-023906. Derived: 9-month figure less the 6-month figure.Report this figure0.9Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Capital expenditure: $197.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Report this figure3.0Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Capital expenditure: $117.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Report this figure7.9Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $8.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001493152-26-036200. Derived: 6-month figure less the 3-month figure.Capital expenditure: $776.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001493152-26-036200. Derived: 6-month figure less the 3-month figure.Report this figure(1.0)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$147.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-17, accession 0001493152-25-023906. Derived: 9-month figure less the 6-month figure.Capital expenditure: $821.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-17, accession 0001493152-25-023906. Derived: 9-month figure less the 6-month figure.Report this figure(3.4)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Capital expenditure: $155.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001493152-26-009549. Derived: 12-month figure less the 9-month figure.Report this figure0.3Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $444.6k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Capital expenditure: $105.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001493152-26-021536.Report this figure(7.0)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001493152-26-036200. Derived: 6-month figure less the 3-month figure.Capital expenditure: $67.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001493152-26-036200. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$194.1mGross margin 85.7%
Diluted EPS$0.25, FY2025
Free cash flow$6.4m, FY2025
LifeMD, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m92.9Revenue, FY2021, twelve months to 2021-12-31$92.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-22, accession 0001493152-23-008560.Report this figure119Revenue, FY2022, twelve months to 2022-12-31$119.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-11, accession 0001493152-24-009581.Report this figure153Revenue, FY2023, twelve months to 2023-12-31$152.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001493152-25-009790.Report this figure155Revenue, FY2024, twelve months to 2024-12-31$154.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549.Report this figure194Revenue, FY2025, twelve months to 2025-12-31$194.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549.Report this figure
Gross margin%80.6%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $74.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-22, accession 0001493152-23-008560.Revenue: $92.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-22, accession 0001493152-23-008560.Report this figure84.3%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $100.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-11, accession 0001493152-24-009581.Revenue: $119.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-11, accession 0001493152-24-009581.Report this figure87.6%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $133.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-11, accession 0001493152-25-009790.Revenue: $152.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001493152-25-009790.Report this figure86.2%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $133.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-10, accession 0001493152-26-009549.Revenue: $154.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549.Report this figure85.7%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $166.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-10, accession 0001493152-26-009549.Revenue: $194.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549.Report this figure
Operating margin%(58.5%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$54.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-22, accession 0001493152-23-008560.Revenue: $92.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-22, accession 0001493152-23-008560.Report this figure(36.5%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$43.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-11, accession 0001493152-24-009581.Revenue: $119.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-11, accession 0001493152-24-009581.Report this figure(9.5%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$14.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-11, accession 0001493152-25-009790.Revenue: $152.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001493152-25-009790.Report this figure(13.2%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$20.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001493152-26-009549.Revenue: $154.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549.Report this figure(4.0%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001493152-26-009549.Revenue: $194.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549.Report this figure
Net margin%(65.6%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$60.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-22, accession 0001493152-23-008560.Revenue: $92.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-22, accession 0001493152-23-008560.Report this figure(38.3%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$45.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-11, accession 0001493152-24-009581.Revenue: $119.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-11, accession 0001493152-24-009581.Report this figure(13.5%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$20.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-11, accession 0001493152-25-009790.Revenue: $152.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001493152-25-009790.Report this figure(13.8%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$21.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001493152-26-009549.Revenue: $154.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549.Report this figure7.4%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $14.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001493152-26-009549.Revenue: $194.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001493152-26-009549.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)(0.60)Diluted EPS, FY2024, twelve months to 2024-12-31−$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-10, accession 0001493152-26-009549.Report this figure0.25Diluted EPS, FY2025, twelve months to 2025-12-31$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-10, accession 0001493152-26-009549.Report this figure
Free cash flow$m(33.3)Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: −$33.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-22, accession 0001493152-23-008560.Capital expenditure: $247.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-22, accession 0001493152-23-008560.Report this figure(23.3)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$22.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-11, accession 0001493152-24-009581.Capital expenditure: $366.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-11, accession 0001493152-24-009581.Report this figure8.6Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $8.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-11, accession 0001493152-25-009790.Capital expenditure: $203.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-11, accession 0001493152-25-009790.Report this figure16.0Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $17.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001493152-26-009549.Capital expenditure: $1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001493152-26-009549.Report this figure6.4Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001493152-26-009549.Capital expenditure: $1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001493152-26-009549.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding LifeMD, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$12.5m3,034,535Added+225,510
FEDERATED HERMES, INC.2026-06-30$11.3m2,747,655Added+1,728,578
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$7.2m1,734,756Added+71,060
STATE STREET CORP2026-06-30$5.4m1,318,784Added+243,376
RENAISSANCE TECHNOLOGIES LLC2026-06-30$4.5m1,079,525Reduced−38,800
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$4.4m1,067,698Added+48,257
Prescott Group Capital Management, L.L.C.2026-06-30$3.7m897,224Added+1,800
BRC Group Holdings, Inc.2026-06-30$2.6m637,319Reduced−234,261
ROYCE & ASSOCIATES LP2026-06-30$2.6m636,124Reduced−565,527
AQR CAPITAL MANAGEMENT LLC2026-06-30$2.6m619,506Added+421,184

Recent filings

All 578 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

LifeMD, Inc., recent filings
FiledFormWhat it isAccession number
2026-09-1514:18 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-042691
2026-08-0520:51 ET10-QQuarterly reportPeriod 2026-06-300001493152-26-036200
2026-08-0520:10 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-036170
2026-06-2212:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-029503
2026-05-0621:24 ET10-QQuarterly reportPeriod 2026-03-310001493152-26-021536
2026-05-0621:04 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-021520
2026-04-3020:05 ETDEF 14AProxy statementPeriod 2026-04-300001493152-26-020419
2026-03-1820:16 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-26-011228
2026-03-1020:56 ET10-KAnnual reportPeriod 2025-12-310001493152-26-009549
2026-03-0920:37 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-009380

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 10, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
948320
Tickers
LFMD, LFMDP
Exchange
Nasdaq
SIC code
8011 Services-Offices & Clinics of Doctors of Medicine
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Accelerated filer
Former names
CONVERSION LABS, INC. (to 2021-02-22); Immudyne, Inc. (to 2018-06-19)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:29 ET. Listed shows no prices and gives no investment advice.